Pancrelipase controlled-release (Digestive Care)

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NamePancrelipase controlled-release (Digestive Care)
Drug Alias NamePancrecarbPancrelipase delayed release capsules (Digestive Care)Pertzymepancrelipase replacement therapyPancrecarb MS-16 +[6] 
ClassificationNatural product/Extract > Animal extractBiologics
Mechanisms of ActionEnzyme replacements
TargetsNot applicable
Therapy Area/IndicationsExocrine Pancreatic InsufficiencyCystic FibrosisPancreatic Neoplasms
Global Approved IndicationsExocrine Pancreatic Insufficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/05/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDigestive Care Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDigestive Care Inc
Active IndicationsExocrine Pancreatic Insufficiency
Inactive IndicationsCystic FibrosisPancreatic Neoplasms

Other Information

ATC CodeA09AA02
Related LinksN/A